While pharma is not synchronized with the boom and bust of the general economy, lessons from the business cycle facing manufacturers can enable the pharmaceutical industry to tackle the problems it faces, writes Chris Hart of McKinney Rogers.
Chris Hart
Advertisement
Chris Hart is a UK partner of global business performance consultancy McKinney Rogers.
Articles by Chris Hart
Advertisement
Latest Updated Articles
- What pharma can learn from general manufacturing in a recession
Published: September 16th 2009 | Updated:
Advertisement
Advertisement
